RU2004105956A - NEW VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR APPLICATION AS ANTI-DIABETIC MEDICINES, etc. - Google Patents
NEW VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR APPLICATION AS ANTI-DIABETIC MEDICINES, etc. Download PDFInfo
- Publication number
- RU2004105956A RU2004105956A RU2004105956/04A RU2004105956A RU2004105956A RU 2004105956 A RU2004105956 A RU 2004105956A RU 2004105956/04 A RU2004105956/04 A RU 2004105956/04A RU 2004105956 A RU2004105956 A RU 2004105956A RU 2004105956 A RU2004105956 A RU 2004105956A
- Authority
- RU
- Russia
- Prior art keywords
- allyloxy
- bis
- acetic acid
- phenyl
- chlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Claims (42)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101154 | 2001-07-30 | ||
DKPA200101154 | 2001-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2004105956A true RU2004105956A (en) | 2005-03-27 |
Family
ID=8160643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2004105956/04A RU2004105956A (en) | 2001-07-30 | 2002-07-05 | NEW VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR APPLICATION AS ANTI-DIABETIC MEDICINES, etc. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1414778A1 (en) |
JP (1) | JP2004536150A (en) |
KR (1) | KR20040019087A (en) |
CN (1) | CN1537093A (en) |
BR (1) | BR0211414A (en) |
CA (1) | CA2452665A1 (en) |
CZ (1) | CZ2004133A3 (en) |
HU (1) | HUP0401575A2 (en) |
IL (1) | IL159547A0 (en) |
MX (1) | MXPA04000891A (en) |
NO (1) | NO20040389L (en) |
PL (1) | PL366401A1 (en) |
RU (1) | RU2004105956A (en) |
WO (1) | WO2003011807A1 (en) |
ZA (1) | ZA200400161B (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091245B2 (en) | 2002-09-05 | 2006-08-15 | Novo Novdisk A/S | Compounds, their preparation and use |
MXPA05004402A (en) * | 2002-10-28 | 2005-07-26 | Novo Nordisk As | Novel compounds and their use as prar-modulators. |
BR0315667A (en) * | 2002-10-28 | 2005-09-06 | Novo Nordisk As | Compound, use of a compound, pharmaceutical composition, and method for treating |
ITRM20030305A1 (en) * | 2003-06-20 | 2004-12-21 | Sigma Tau Ind Farmaceuti | PREPARATION OF NEW DERIVATIVES OF FENYL ACID OR PHENOXYKYL MONO AND DIACARBOXY USEFUL IN THE TREATMENT OF HYPERGLYCAEMIA AND TYPICAL HYPERTRIGLYCERIDEMIA OF TYPE II DIABETES. |
WO2005042478A2 (en) | 2003-09-19 | 2005-05-12 | Janssen Pharmaceutica, N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
DK1670744T5 (en) | 2003-09-19 | 2012-11-26 | Janssen Pharmaceutica Nv | 4 - ((Phenoxyalkyl) -thio) -phenoxyacetic acids and analogs |
EP1745014B1 (en) * | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Novel compounds, their preparation and use |
SI1942898T2 (en) | 2005-09-14 | 2014-08-29 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetes |
JO3006B1 (en) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | Novel Lysine Salts of 4-((Phenoxy Alkyl)Thio)-Phenoxy Acetic Acid Derivatives |
CN102675221A (en) | 2005-09-16 | 2012-09-19 | 武田药品工业株式会社 | Intermediate in method for preparing pyrimidinedione derivative |
CN103224477A (en) | 2005-12-22 | 2013-07-31 | 高点制药有限责任公司 | Phenoxy acetic acids as PPAR delta activators |
PE20080188A1 (en) | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | DERIVATIVES OF BENZOAZEPINE-OXY-ACETIC ACID AS PPAR-DELTA AGONISTS USED TO INCREASE HDL-C, REDUCE LDL-C AND REDUCE CHOLESTEROL |
KR100693132B1 (en) * | 2006-06-23 | 2007-03-14 | 동해전장 주식회사 | Relay operation checking device of junction box |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US20120168303A1 (en) * | 2011-01-05 | 2012-07-05 | Sueng-Nien Kao | Salt water activated emergency lighting device |
CN103467405B (en) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | Tetrazole carboxylic acid compounds, and preparation method and application thereof |
CN103467409B (en) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | Substituted tetrazole carboxylic acid compounds and application thereof |
CN103467407B (en) * | 2013-09-03 | 2015-04-22 | 浙江医药高等专科学校 | Tetrazole carboxylic acid compounds and application thereof |
CN103467406B (en) * | 2013-09-03 | 2014-12-17 | 浙江医药高等专科学校 | Halogen-substituted tetrazole carboxylic acid compounds, and preparation method and application thereof |
CN103467408B (en) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | Tetrazole carboxylic acid compounds and application thereof |
WO2022020376A1 (en) | 2020-07-22 | 2022-01-27 | Reneo Pharmaceuticals, Inc. | Crystalline ppar-delta agonist |
WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0098690B1 (en) * | 1982-06-14 | 1987-09-09 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
WO1997043241A1 (en) * | 1996-05-13 | 1997-11-20 | Nippon Shinyaku Co., Ltd. | Substituted ethylene compounds and drugs |
JP2002542218A (en) * | 1999-04-20 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their manufacture and use |
PL357010A1 (en) * | 2000-01-28 | 2004-07-12 | Novo Nordisk A/S | Propionic acid derivatives and their use in the treatment of diabetes and obesity |
-
2002
- 2002-07-05 KR KR10-2004-7001417A patent/KR20040019087A/en not_active Application Discontinuation
- 2002-07-05 BR BR0211414-3A patent/BR0211414A/en not_active IP Right Cessation
- 2002-07-05 WO PCT/DK2002/000471 patent/WO2003011807A1/en not_active Application Discontinuation
- 2002-07-05 IL IL15954702A patent/IL159547A0/en unknown
- 2002-07-05 EP EP02745186A patent/EP1414778A1/en not_active Withdrawn
- 2002-07-05 RU RU2004105956/04A patent/RU2004105956A/en not_active Application Discontinuation
- 2002-07-05 CA CA002452665A patent/CA2452665A1/en not_active Abandoned
- 2002-07-05 JP JP2003517001A patent/JP2004536150A/en active Pending
- 2002-07-05 CN CNA028150996A patent/CN1537093A/en active Pending
- 2002-07-05 CZ CZ2004133A patent/CZ2004133A3/en unknown
- 2002-07-05 MX MXPA04000891A patent/MXPA04000891A/en unknown
- 2002-07-05 HU HU0401575A patent/HUP0401575A2/en unknown
- 2002-07-05 PL PL02366401A patent/PL366401A1/en not_active Application Discontinuation
-
2004
- 2004-01-09 ZA ZA200400161A patent/ZA200400161B/en unknown
- 2004-01-29 NO NO20040389A patent/NO20040389L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0211414A (en) | 2004-08-17 |
WO2003011807A1 (en) | 2003-02-13 |
JP2004536150A (en) | 2004-12-02 |
CA2452665A1 (en) | 2003-02-13 |
CZ2004133A3 (en) | 2004-06-16 |
KR20040019087A (en) | 2004-03-04 |
PL366401A1 (en) | 2005-01-24 |
HUP0401575A2 (en) | 2004-11-29 |
CN1537093A (en) | 2004-10-13 |
EP1414778A1 (en) | 2004-05-06 |
NO20040389L (en) | 2004-01-29 |
MXPA04000891A (en) | 2004-05-21 |
IL159547A0 (en) | 2004-06-01 |
ZA200400161B (en) | 2004-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2004105956A (en) | NEW VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR APPLICATION AS ANTI-DIABETIC MEDICINES, etc. | |
RU2001131111A (en) | NEW COMPOUNDS, THEIR PRODUCTION AND APPLICATION | |
DK2278960T3 (en) | DOSAGE regimen for a selective SIP1 RECEPTOR AGONIST | |
RU2008123000A (en) | COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | |
CA2513092A1 (en) | Compounds for the treatment of metabolic disorders | |
JP2009528375A5 (en) | ||
JP2009531280A5 (en) | ||
CA2521621A1 (en) | Compounds for the treatment of metabolic disorders | |
JP2009537559A5 (en) | ||
RU2004114875A (en) | DICARBOXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND THERAPEUTIC USE | |
JP2008530242A5 (en) | ||
JP2005528393A5 (en) | ||
RU2003121236A (en) | AILATED AMIDES OF FURAN- AND THIOPHENCARBOXYLIC ACIDS WITH LOCKING POTASSIUM CHANNEL ACTION | |
JP2005538062A5 (en) | ||
CN101947218A (en) | The method of modulating calcium ion-release-activated calcium ion channels | |
RU2006105717A (en) | PIPERASIN DERIVATIVES AND THEIR APPLICATION AS THERAPEUTIC AGENTS | |
JP2006528986A5 (en) | ||
RU2007108415A (en) | NEW CYCLIC DERIVATIVE OF AMINOBENZOIC ACID | |
RU2010141823A (en) | COMPOUNDS AND METHOD FOR REDUCING URIC ACID | |
CA2521589A1 (en) | Compounds for the treatment of metabolic disorders | |
CA2502297A1 (en) | Compounds for the treatment of metabolic disorders | |
RU2005109555A (en) | NEW VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR THERAPEUTIC APPLICATION | |
JP2009528275A5 (en) | ||
EP2785341A1 (en) | Aryl derivatives for controlling ectoparasites | |
RU2006108572A (en) | COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20060728 |